Open access platform accelerates drug discovery and development

"The Centre for Therapeutic Target Validation (CTTV) has launched a new web platform for life-science researchers that helps them to identify therapeutic targets for new and repurposed medicines. Establishing the validity of an association between a disease and biological target for a drug can be extremely challenging and expensive. To address this challenge, the CTTV, a collaboration between GSK, the Wellcome Trust Sanger Institute and the European Bioinformatics Institute (EMBL-EBI), has created a web-based platform (www.targetvalidation.org) that draws on public data resources to help drug discovery ..."